The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis

Ann Rheum Dis. 2010 Sep;69(9):1730-1. doi: 10.1136/ard.2009.117952. Epub 2010 Apr 13.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Arthritis, Rheumatoid / genetics*
  • Autoantibodies / blood*
  • Cohort Studies
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Mutation, Missense
  • Peptides, Cyclic / immunology*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22 / genetics*

Substances

  • Autoantibodies
  • Peptides, Cyclic
  • cyclic citrullinated peptide
  • PTPN22 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22